Kidney Medullary Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Kidney Medullary Carcinoma

subtype

Identifier: CI-CAN-00007926
Entity page: /cancer/kidney-medullary-carcinoma ↗
Edges: 19

Neighbours: 9 drugs10 trials
Drawn: 19 of 19 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Kidney Medullary Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived9 of 9
→ investigated in trials for	Cabozantinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Kidney Medullary Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants

Kidney Medullary Carcinoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07438626Phase 2 · recruiting Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma · condition mapped ALIAS · 10 trials mapped (6 active)	—	—	SMARCB1-Deficient Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03274258Phase 2 · terminated Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03587662Phase 2 · completed Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05286801Phase 1/Phase 2 · active not recruiting Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (6 active)	—	—	Kidney Medullary Carcinoma	1	Observed	clinicaltrials	graph →